An Open Label Extension of Study HGT-SAN-093 Evaluating the Safety and Efficacy of HGT-1410 (Recombinant Human Heparan N Sulfatase) Administration via an Intrathecal Drug Delivery Device in Pediatric Patients with Mucopolysaccharidosis Type IIIA Disease
|Effective start/end date||1/11/16 → 6/1/18|
- SHIRE HUMAN GENETIC THERAPIES, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.